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Osteochondrosis (OC) is the most important developmental orthopaedic disease in the horse. Despite some decades of research, much of
the pathogenesis of the disorder remains obscure. Increasing knowledge of articular cartilage development in juvenile animals led to the
presumption that the role of collagen in OC might be more important than previously thought. To study collagen characteristics of both
cartilage and subchondral bone in young (5 and 11 months of age) horses, samples were taken of subchondral bone and articular cartilage
from a group of 43 Dutch Warmblood foals and yearlings that suffered from varying degrees of OC. Based on a histological classification,
lesions were graded as early, middle and end stage. Collagen content and some posttranslational modifications (lysyl hydroxylation,
hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) cross-links) were determined, as was proteoglycan content. Data were
compensated for site effects and analysed for differences due to the stage of the lesion.
In early lesions total collagen was significantly decreased in both cartilage and subchondral bone of 5- and 11-month-old foals. Also in
cartilage, HP cross-linking was reduced in the early lesions of 5- and 11-month-old foals, while LP cross-linking was decreased in
subchondral bone of the end-stage lesions of both 5- and 11-month-old foals. Hydroxylysine content was unaffected. Collagen content
remained reduced in cartilage from middle- and end-stage lesions, but returned to normal in subchondral bone. In cartilage there was a
decrease in proteoglycan content in the end-stage lesions of both age groups.
Thus, alterations of the collagen component, but not of the proteoglycan component, of the extracellular matrix might play a role in early
OC. More severe lesions show a more general picture of an unspecific repair reaction. Biomarkers of collagen metabolism can be expected to
be good candidates for early detection of OC.
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1. Introduction bone [1]. The last parts of the long bones that undergo thisOsteochondrosis (OC) can be defined as a disturbance of
the process of endochondral ossification, i.e. as an aberra-
tion of the physiological process that occurs during growth
of the young individual in which the cartilaginous prede-
cessors of the osseous components of the skeleton turn to0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2004.05.002
Abbreviations: dw, dry weight; GAG, glycosaminoglycan; HP,
hydroxylysylpyridinoline; LP, lysylpyridinoline; HPLC, high performance
liquid chromatography; Hyl, hydroxylysine
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virtually all growth in longitudinal direction of the bone,
and the epiphyses. Where the physes of long bones close
and mineralise completely when growth ceases, the epiph-
yses retain a thin layer of cartilage that serves as articular
cartilage throughout the life of the individual. Disturbances
in the process of endochondral ossification occur in many
species and may have different clinical manifestations,
depending on where and when problems arise. In man,
osteochondrosis juvenilis Scheuermann is a relatively rare,
but well-known clinical entity [2,3], in chicken so-called
dyschondroplasia is common in the (tibial) growth plate [4],
and in dogs, pigs and horses osteochondrosis (OC) or
osteochondritis dissecans (OCD) is common in the epiphy-
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in the horse is of special importance. It has been estimated
that 20,000–25,000 foals are born annually in Northwestern
Europe alone that will suffer from some degree of OC [6].
Although most of these animals will eventually be able to
perform, surgery is required in many cases, which means
that the disease causes a vast loss to the equine industry,
both in economic terms and in terms of animal welfare.
The principal event in the process of endochondral
ossification is the transformation of the cartilage extracel-
lular matrix (ECM) into an ECM that is typical for bone.
Cartilage ECM is characterised by a collagen type II
network as the structural component that is interspersed
with strongly hydrated proteoglycan aggregates. Bone has a
heavily mineralised organic matrix that itself has collagen
type I molecules as structural units with again proteogly-
cans as the major non-collagenous organic component. In
the process of endochondral ossification, most if not all
ECM components will have to be replaced or remodelled.
It seems, based on recent literature, that the role of collagen
in both cartilage and bone is very prominent in processes of
remodelling of the ECM, making it likely that collagen
may be a key factor in certain pathological conditions as
well. In callus formation in bone, Wassen et al. [7]
demonstrated that it is the collagen matrix that largely
directs the process of mineralisation. Obviously, minerali-
sation is a key element in the process of endochondral
ossification and it can be speculated that collagen may have
a role here as well. In cartilage, Brama et al. [8] showed
that there is a very active turnover of the collagen matrix in
the young foal that results in a distinct topographical
heterogeneity in the mature animal. This biochemical
heterogeneity has been shown to match with site differ-
ences in biomechanical loading [9] and is thought to be an
adaptation of the tissue to the biomechanical challenges it
is exposed to once the joints are started to be loaded after
birth. This process of remodelling and modification seems
to be a general phenomenon in at least a number of
mammalian species [10]. In the horse, it has been shown
to be most active in the first months after birth and to
decline rapidly after this period [8]. It is in this same period
that endochondral ossification is at its height and that
osteochondrotic lesions are known to develop [11,12].
The process of endochondral ossification and the formation
of topographical heterogeneity over the articular surface are
therefore concurrent processes, both implying a very active
collagen turnover. Although the exact pathogenesis of OC
has not been elucidated so far [13], there is increasing
evidence that a disturbance in collagen metabolism may be
at least one of the key factors. Various studies have
focussed on the distribution of proteinases that may be
implicated in collagen metabolism in normal articular
cartilage and in samples from osteochondrotic lesions
[14–17]. Laverty et al. [18] found alterations in cartilage
type II-procollagen in synovial fluids from horses with OC
and in another study showed evidence for a significantincrease in type II collagen cleavage, but no evidence for
an increase in proteoglycan degradation [19].
A major drawback of most of the studies mentioned is
that they are either based on very limited numbers of cases,
or make use of samples from clinical cases that were
presented for surgical removal of loose osteochondrotic
fragments. In the latter case this means that it is the end
stage of the disease that is studied. Osteochondrosis has
been shown to be a very dynamic disorder in which lesions
may become visible during the first months of life and then
either develop further or regress, partially or even complete-
ly [11,20,21]. These observations have led to the idea that
clinical OC is determined by two separate processes: the
occurrence of lesions, i.e. the real pathogenesis, and the
ensuing repair process of the lesion after it has formed [22].
Although both processes have effect on the ultimate inci-
dence of clinical OC at the age when the horse is put into
use, they are not necessarily influenced by the same factors.
Whereas pathogenetical factors can be specific for OC,
repair can be presumed to be a fairly general process that
is influenced by the metabolic status of the cartilage, but is
largely independent from the actual cause of the damage. In
this line, it has recently been shown that a good copper
status at birth in foals positively influenced the repair
process of OC lesions, but had no effect on the pathogenesis
of these lesions [23]. When studying established OC lesions,
the relatively unspecific repair process will be focussed at,
making it difficult to discriminate between various causes of
cartilage damage [24,25]. It may be expected that the study
of less mature lesions will yield more relevant information
that might be useful for gaining a better insight in the early
events of OC.
In order to test the hypothesis that disturbances in
collagen metabolism are major events in early equine OC,
which will be reflected in the make-up of the collagen
network of the ECM, the present study focuses on the
biochemical composition of the extracellular matrix in a
large number of young horses in various, well-defined stages
of osteochondrosis, including very early stages. The analysis
includes the proteoglycan component of the ECM, but
emphasises collagen and its posttranslational modifications.
As osteochondrosis is a disturbance of the process in which
cartilage changes into bone, subchondral bone samples were
included in this analysis. We investigated total collagen
content, hydroxylysine content, collagen cross-linking, and
glycosaminoglycan (GAG) content in early-, middle-, and
end-stage osteochondrotic lesions in foals and yearlings.2. Materials and methods
2.1. Origin of the foals and experimental design
In this study, 43 Dutch Warmblood foals were used.
These foals took part in a large research project on the
development of osteochondrosis and the influence of exer-
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system. This project is extensively discussed elsewhere,
including animal welfare and ethical considerations [6].
Briefly, the foals were the offspring of eight stallions with
radiographically proven osteochondrosis in either the fem-
oropatellar (n = 4) or the tibial tarsal joint (n= 4) and the
mare population of the Institute for Horse Husbandry in
Lelystad, the Netherlands. Four out of 43 of these mares had
radiological osteochondrosis in the tibial tarsal joint and
seven in the femoropatellar joint.
At birth, the foals were randomly assigned to three
exercise regimens that included free pasture exercise, box-
rest and box-rest together with a specific training programme.
At the age of 5 months all foals were weaned. Twenty-four
were randomly selected and euthanased by an overdose of
pentobarbital directly after weaning. The remaining 19 foals
were housed together in a loose house with access to a small
paddock for an additional 6 months before being sacrificed at
the age of 11 months. As the exercise regimens did not
significantly affect the manifestation of OC [12], this factor
was not taken into account in the present study.
2.2. Sample collection
Directly after euthanasia, the right femoropatellar and
tibial tarsal joints were dissected. Samples were taken from
two different joints: the femoropatellar joint and the tibial
tarsal joint. In the femoropatellar joint two sites were
sampled, which were located at the lateral and the medial
trochlear ridge of the femur, respectively. In the tibial tarsal
joint samples were taken from four sites. These were: the
medial and lateral trochlear ridge of the talus and the medial
malleolus and the cranial part of the sagittal ridge of the
tibia. Samples were taken from these six sites in all animals,
irrespective whether there were signs of osteochondrosis or
not. Any osteochondrosis present was scored on a scale of 0
to 4 as described by Van Weeren and Barneveld [12] and
based on the histological description of Henson et al. [26].
In this scale, grade 0 represents normal tissue, grade 1
features an indentation of the ossification front without
histological signs of OC, in grade 2 there is loss of the
normal, regular columnar arrangement of the chondrocytes
and chondrone formation, grade 3 shows additionally fis-
sures and necrosis of the deep layers of the cartilage, in
grade 4 there is an overt lesion with a semi-loose fragment,
and in grade 5 there is a loose fragment in the joint. Sites
with scores of 2 or more were considered osteochondrotic.
Sites with scores 0 were used as controls. Scores of 1 were
considered inconclusive and hence not classified. In this
classification, grade 2 lesions can be considered early stage
OC, grade 3 middle stage and grades 4–5 end stage. In the
present paper they are indicated as such.
Care was taken that the cartilage sample included the full
thickness of the articular cartilage down to, but not includ-
ing, the subchondral bone. Samples were cut in half, one for
GAG analysis and one for determination of the collagenparameters. After recording wet weight, samples were
lyophilised and dry weight was recorded.
Subchondral bone samples of approximately 2 mm in
thickness were harvested after removal of the cartilage layer
by use of a woodcraft knife. Dry weight was recorded after
lyophilization of the sample. Finally, all samples were
sealed, frozen, and stored at  20 jC until analysis as a
single batch.
2.3. Determination of total collagen, and posttranslational
modifications of collagen
Before hydrolysis, subchondral bone samples were dem-
ineralised three times with 1-ml 0.5 M EDTA (pH 7.4)
during 24 h for each step. To remove excessive EDTA, the
samples were washed with water (three times during 6
h each) and dried in vacuo. Further processing was similar
for cartilage and subchondral bone samples. After hydrolysis
in 6 N HCl, amounts of hydroxyproline (Hyp), hydroxyly-
sine (Hyl), and the cross-link hydroxylysylpyridinoline (HP)
and lysylpyridinoline (LP) were quantified by high perfor-
mance liquid chromatography (HPLC) [27]. Collagen con-
tent was calculated from the Hyp content assuming that a
collagen triple helix contains 300 Hyp residues, and choos-
ing an average molecular weight of 300 kDa for collagen
[27]. Collagen is expressed as mg collagen/mg dw. Levels of
Hyl and the cross-links HP and LP were expressed as moles
per mole of triple helical collagen (mol/mol collagen).
2.4. Determination of the sulfated GAG content
Prior to GAG analysis, cartilage samples were digested
with 1 U/ml papain (Sigma, St. Louis, USA) in 400 Al of 50
mM phosphate buffer (pH 6.5), containing 2 mM Na2EDTA
and 2 mM cysteine, for 4 h at 65 C. Sulfated GAGs were
analysed by a modified 1,9-dimethylmethylene blue
(DMMB) assay described by Farndale et al. [28]. To 40-
Al sample, 40-Al 3% (w/v) bovine serum albumin (Sigma)
and 1 ml of reagent (46 AM DMMB (Sigma), 40 mM
glycine and 42 mM NaCl (adjusted to pH 3.0 with HCl)
were added and after 30 min the absorbance at 525 nm was
measured. The assay was standardised with shark chondroi-
tin sulfate (Sigma).
2.5. Data analysis
Anatomical site and age differences were analysed with a
two-way analysis of variance (two-way ANOVA); P values
below 0.05 were considered significant. Interactions be-
tween anatomical site and OC-severity were analysed using
three-way ANOVA (parameters: anatomical site, age and
OC-severity). Variation due to differences in anatomical site
was compensated for in order to analyse statistically the
difference between normal and osteochondrotic samples in
itself. To achieve this, each value was compensated for the
average site effect of the corresponding age. The values of
Fig. 1. Age differences on total collagen content and the average lesion severity in juvenile horses. (A) Influence of age and the anatomical site where the
sample was taken on the total collagen content of non-osteochondrotic cartilage in 5- (open bars) (n= 24) and 11-month-old (solid bars) (n= 19) foals. Collagen
content was deduced from hydroxyproline content as described in Section 2. Cartilage samples were taken from the lateral (lT) and medial (mT) trochlear ridge
of the femur (Fem), and the talus (Tal), and the medial malleolus (Timm) and cranial part of the sagittal ridge (Tis) of the tibia. (B) Average severity of
osteochondrotic lesions that were found within 26 preselected joints of 40 individual horses (with osteochondrotic lesions) of ages 5 (n= 23) or 11 (n= 17)
months. Lines represent geometric meanF 95% confidence interval. *P < 0.05 (Mann Whitney test).
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averaged and considered as one data point, restricting the
number of values per foal to one normal value, and none to
three osteochondrotic values, dependent on the occurrence
and grade of osteochondrotic lesions. For statistical analysis
of multiple groups (i.e. osteochondrotic grades and age), a
two-way ANOVAwas used, in combination with Dunnett’s-
T3 post hoc (equal variance is not assumed) test to evaluate
the level of significance. Values were expressed as
meanF S.D., unless otherwise stated.3. Results
3.1. Anatomical site and age differences in normal tissue
Considerable anatomical site and age differences were
observed in most of the parameters in normal tissue of bothFig. 2. Total collagen content (meanF S.E.) of cartilage (A) and subchondral bone
5- (open bars) and 11-month-old (solid bars) foals. Collagen content was deduce
corrected anatomical site variations. n= 43 (24 + 19), 13 (10 + 3), 5 (3 + 2) and 8
brackets represent n for 5 and 11 months, respectively. Asterisks indicate statistica
** and *** represent P < 0.05, P< 0.01 and P < 0.001, respectively.cartilage and subchondral bone. The most prominent site
and age differences were observed in the collagen content of
normal cartilage tissue (Fig. 1A). Age appeared to have only
an effect on the collagen content of cartilage samples that
were taken from the tibial tarsal joint, whereas age had no
effect on samples that were taken from the femoropatellar
joint (Fig. 1A). The average grade of osteochondrotic
lesions found in 26 preselected joints of each of the foals
(for calculations early-, middle- and end-stage lesions were
ranked as described in Section 2) indicates that there was a
gradual shift in the distribution of lesions from the less
severe early lesions in the 5-month-old foals (2.85F 0.10,
n = 23) to the more server end-stage lesions in the 11-month-
old foals (3.20F 0.13, n= 17) (P < 0.05, Mann–Whitney
test) (Fig. 1B).
Three-way ANOVA (parameters: anatomical site, age
and OC-severity) revealed that there was no interaction
between anatomical site and OC-severity. Because of this,(B) samples in increasing pathological stages of osteochondrotic lesions in
d from hydroxyproline content as described in Section 2. All values were
(5 + 3) for control, early, middle and end, respectively; numbers between
l differences between control and the indicated OC-severity group, where *,
Fig. 3. Level of the hydroxylysine (Hyl) per collagen triple helix (meanF S.E.) in cartilage (A) and subchondral bone (B) samples with increasing pathological
stages of osteochondrotic lesions in 5- (open bars) and 11-month-old (solid bars) foals. All values were corrected for anatomical site variations. n= 43 (24 + 19),
13 (10 + 3), 5 (3 + 2) and 8 (5 + 3) for control, early, middle and end, respectively; numbers between brackets represent n for 5 and 11 months, respectively.
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value for the average site effect of the corresponding age.
Obviously, after correction of the samples for site effects,
differences within this parameter were completely eliminat-
ed (P>0.96). Also no statistical interactions were observed
between age and OC-severity (two- and three-way
ANOVA). For this reason, we do not go into detail about
age effects, since these are extensively discussed earlier by
Brama et al. [29].
3.2. Biochemical parameters after compensation for site
effects
3.2.1. Collagen content
A highly significant (P < 0.001) decrease in collagen
content of cartilage in osteochondrotic lesions was observed
(0.56F 0.04 (n = 43), 0.48F 0.04 (n = 13), 0.49F 0.07
(n = 5) and 0.47F 0.14 (n = 8) mg/mg dw for control,
early-, middle-, and end-stage lesions, respectively). TheFig. 4. Level of the HP collagen cross-linking (meanF S.E.) in cartilage
samples with increasing pathological stages of osteochondrotic lesions in 5-
(open bars) and 11-month-old (solid bars) foals. All values were corrected
for anatomical site variations. n= 43 (24 + 19), 13 (10 + 3), 5 (3 + 2) and
8 (5 + 3) for control, early, middle and end, respectively; numbers between
brackets represent n for 5 and 11 months, respectively. Asterisks indicate
statistical differences between control and the indicated OC-severity group,
where ** represents P < 0.01.lower collagen content was clearly present in the mildest
form of osteochondrosis, and was stable in the more severe
grades (Fig. 2A). In subchondral bone there was a signifi-
cant (P < 0.01) decrease in collagen content in early lesions
(0.15F 0.02 (n = 13) mg/mg dw) compared to the control
group (0.21F 0.11 (n = 43) mg/mg dw) (Fig. 2B). However,
collagen content tended to increase in the middle- and end-
stage forms of osteochondrosis (0.23F 0.03 (n = 5) and
0.25F 0.08 (n = 8) mg/mg dw, respectively), although this
increase was not significant.
3.2.2. Posttranslational modifications of collagen
The hydroxylysine level was very constant in both
control and osteochondrotic samples from cartilage
(50.7F 3.3 (n= 43) mol/mol triple helix) as well as from
subchondral bone (19.1F 2.1 (n = 43) mol/triple helix)
(Fig. 3).
Collagen HP cross-links were significantly decreased in
cartilage from early lesions (0.86F 0.08 (n = 43) vs.
0.72F 0.15 (n = 13) mol HP/mol triple helix, for controlFig. 5. Level of the LP collagen cross-linking (meanF S.E.) in subchondral
bone samples with increasing pathological stages of osteochondrotic lesions
in 5- (open bars) and 11-month-old (solid bars) foals. All values were
corrected for anatomical site variations. n= 43 (24 + 19), 13 (10 + 3), 5
(3 + 2) and 8 (5 + 3) for control, early, middle and end, respectively;
numbers between brackets represent n for 5 and 11 months, respectively.
Asterisks indicate statistical differences between control and the indicated
OC-severity group, where * represents P< 0.05.
Fig. 6. GAG content (meanF S.E.) of articular cartilage of increasing
pathological stages of osteochondrotic lesions in 5- (open bars) and 11-
month-old (solid bars) foals. All values were corrected for anatomical site
variations. n= 43 (24 + 19), 13 (10 + 3), 5 (3 + 2) and 8 (5 + 3) for control,
early, middle and end, respectively; numbers between brackets represent n
for 5 and 11 months, respectively. Asterisks indicate statistical differences
between control and the indicated OC-severity group, where * represents
P < 0.05.
C.H.A. van de Lest et al. / Biochimica et Biophysica Acta 1690 (2004) 54–62 59and early lesions, respectively, P < 0.01). However, this
effect disappeared when the lesions worsened (Fig. 4). No
differences were found in the HP cross-links of subchondral
bone samples.
The level of LP cross-links in cartilage was found to be
very low, and just above the detection limit. For this reason,
no reliable data could be provided. In subchondral bone the
level of LP cross-links in the control group was about
seven times lower compared to the level of HP cross-links.
LP cross-links in subchondral bone tended to decrease
slowly with worsening of the osteochondrotic lesions. In
severe lesions, this decrease became significant (0.040F
0.009 (n = 43) vs. 0.027F 0.008 (n = 8) mol LP/mol triple
helix, for control and severe lesions, respectively, P < 0.01)
(Fig. 5).
3.2.3. Sulfated GAG content
Sulfated GAG content was only altered in cartilage in the
most severe form of osteochondrosis. In these lesions, GAG
content decreased from 32.3F 10.3 (n = 43) Ag/mg ww for
control cartilage to 20.3F 4.5 (n = 8) Ag/mg ww (Fig. 6). In
subchondral bone the variation in GAG content appeared to
be extremely high; for this reason, no GAG data for this
tissue is provided.4. Discussion
In this study we had the unique opportunity to study the
biochemical changes of early osteochondrotic lesions in a
relatively large number of young animals. Juvenile articular
cartilage is a metabolically very active tissue in which rapid
changes occur, with various processes going on at the same
time. In the process of endochondral ossification, the
cartilaginous precursors of the skeletal long bones gradually
ossify, except for a thin layer of cartilage at the extreme endsof the epiphyses that become the articular cartilage. At the
same time, this articular cartilage gradually assumes a
typical topographical heterogeneity in biochemical make-
up, a process initiated by the onset of articulation and
weightbearing. The biochemical heterogeneity causes dis-
tinct differences in biomechanical characteristics across the
joint surface and allows the joint to counteract successfully
the biomechanical challenges it is exposed to. In the horse,
this process of functional adaptation takes place principally
in the first months of life [8]. Collagen is the major
structural element of the tissues involved and the processes
of remodelling and adaptation can proceed, thanks to the
high collagen metabolism in the young animal. In articular
cartilage this metabolic activity is known to decline expo-
nentially after birth and to become extremely low in mature
individuals. In man, collagen type II turnover time has been
estimated to be between 200 and 400 years [30,31]. Against
this background, the conclusion seems justified that devel-
opmental disorders such as OC can only be studied in young
animals, at least if it is the pathogenesis of the disease that is
subject of study and not the repair process of existing
lesions.
There were interesting age-related site differences in
collagen content between the femoropatellar and the tibial
tarsal joint. In the latter, collagen content increased signif-
icantly from age 5 to age 11 months. This pattern was found
also in the metacarpophalangeal joints of the same animals
[29]. However, in the femoropatellar joint collagen, levels
were already at a higher level at age 5 months and stayed at
that level. There is no easy explanation for this phenome-
non, but it stresses the earlier observation that age-related
changes in equine joints may not progress at the same rate in
all joints [22]. This study focussed at the analysis of the
biochemical composition of cartilage and subchondral bone
in various classes of osteochondrotic lesions. Since the
occurrence and severity of lesions among sites of prove-
nance were rather diverse, all samples were compensated for
site differences before further processing. Two-way
ANOVA revealed no interaction between age and the level
of OC in none of the analysed parameter; meaning that age
had the same effect on all groups of osteochondrotic
severity in all analysed biochemical parameters.
There were distinct differences in collagen characteristics
in the early-, middle- and end-stage lesions. In early lesions
a highly significant decrease in total collagen content was
found, remarkably both in cartilage and in subchondral
bone. It should be realised in this respect that biochemical
analysis of (osteochondrotic) subchondral bone samples has
a potential pitfall. Since in osteochondrosis the border
between cartilage and bone is, by definition, not sharp and
distinct, contamination of subchondral bone samples with
cartilaginous tissue may occur. This was almost certainly the
reason why we failed to establish reliable GAG-values for
subchondral bone as GAGs are much more abundant in
cartilage than in bone. However, for collagen measurement,
cartilage contaminations are less critical as the levels in both
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content persisted in cartilage when the lesions grew older,
but not in subchondral bone. The explanation may be that
the declining metabolic level in cartilage (middle- and end-
stage lesions were more prominent in 11-month-old animals
than in 5-month-olds, Fig. 1B) affects the ability of this
tissue to regain normal collagen levels. Collagen metabo-
lism in bone remains high throughout life, thus enabling a
quick recuperation. It therefore seems that a disturbance in
collagen metabolism is an early event in OC in both
cartilage and subchondral bone.
In cartilage, but not in subchondral bone, the degree of
HP-cross-linking was decreased as well. Reduced cross-
linking in cartilage from osteochondrotic lesions was earlier
found in studies in which these lesions were provoked by
means of inducing copper-deficiency [32,33]. It is known
that the HP/LP ratio has a strong relationship with mineral-
isation in callus tissue [7]. This ratio is a result of a specific
packing of intra-fibrillar collagen molecules [34], and thus of
the spatial arrangement of these fibrils. Although we failed to
analyse LP in cartilage, we too found a relation between low
HP levels and lack of mineralisation in early OC lesions. It is
therefore tempting to speculate that a similar influence of the
collagen network might exist in the process of endochondral
ossification and that spatial arrangements of the collagen
fibrils may have a pivotal role herein.
The decrease in collagen levels may be caused by various
mechanisms. First, the rate of collagen synthesis can be
affected. The process of collagen synthesis is extremely
active in the neonate and in the early postnatal period when
mineralisation is most active, reflected by high levels of
type X collagen and chondrocalcin (the C-propeptide of
type II collagen) [35–37]. The highly active processes are
more vulnerable to disturbances than low-rate processes.
The change for such a disturbance to happen is greater when
the growth rate is high, which is a well-known risk factor for
the development of OC [1]. Second, the incorporation of
newly formed collagen may be disturbed, which can lead to
a too early release of these molecules from the matrix.
Third, collagen breakdown may increase due to, for exam-
ple, increased proteolytic activity. Based on the present
study, no discrimination can be made between these possi-
ble mechanisms. Further, two or more mechanisms may be
of importance at the same moment or sequentially in time.
However, taking into account information from other recent
studies, some speculations can be made.
Billinghurst et al. [38] showed alterations of biomarkers
of collagen metabolism in serum samples from the same
group of animals as used in this study. In particular, it
appears that elevations in the serum levels of a marker of
type II collagen synthesis, CPII, during the first year of life,
is a consistent indicator of foals that have or will develop
OC. They also showed a decrease in the serum levels of the
234CEQ-epitope, which is a marker specific for type II
collagen degradation, and an increase in serum COL2-3/
4Cshort, a less specific biomarker for type I and type IIcollagen degradation, in 5-month-olds with high OC scores
compared to low OC scores. At the age of 5 months, most
lesions are in an early phase (Fig. 1B). Brama et al. [39]
found a sharp age-related decrease in MMP-1 (tissue colla-
genase) levels in synovial fluid from horses, reflecting the
decline in collagen metabolism, but in another study found a
relatively higher level of MMP-1 activity in foals affected
by OC compared to age-matched controls without OC
(unpublished data). MMPs are known to play an active role
in cartilage repair and remodelling [40–42]. Van den
Hoogen et al. [43] demonstrated a higher metabolic activity
of chondrocytes originating from osteochondrotic lesions in
young foals compared to chondrocytes from more mature
lesions in yearlings. Together, these findings seem to
indicate that in early osteochondrosis overall metabolic
activity is increased, including collagen turnover, but spe-
cific collagen type II breakdown seems to be impaired. This
leads to a lagging behind in development of the ECM of the
affected area, giving it a more juvenile phenotype and hence
a lower collagen level.
The importance of collagen metabolism during endo-
chondral ossification and the aberration of collagen metab-
olism as an important feature of early OC are supported by
recent reports on enzymatic activity in equine articular
cartilage and on collagen degradation products in explant
cultures. Hernandez-Vidal et al. [14,15] showed differences
in distribution patterns of the cathepsins B and D in
osteochondrotic cartilage compared to normal using immu-
nolocalisation. Gla¨ser et al. [17] have provided evidence for
differences and site-specific roles of cathepsins B and L in
articular cartilage during the process of endochondral ossi-
fication. The cysteine proteinases cathepsin B and L have
been shown to have collagenolytic activity as well [44–46].
Laverty et al. [19] found an increase in the COL2-3/4Cshort-
epitope, but not in proteoglycan degradation products in
explants of osteochondrotic cartilage that were taken from
young ( < 12 months) horses. Finally, in a recent study,
Squires et al. [47] found that in human osteoarthritic
cartilage a reduced collagen content is also associated with
an increased collagenase activity, suggesting that a drop in
collagen content is more commonly associated with an
increased cleavage of collagen by collagenase.
It should be pointed out that, although data from this
and other studies point to an important mechanistic role of
collagen metabolism in the early phase of OC, there is no
proof that changes in collagen metabolism are primary
events. There are many putative factors involved in the
process of endochondral ossification, which is a multi-step
process regulated by a complex network of signalling
systems [48]. The process of chondrocytic hypertrophy,
apoptosis and mineralisation is governed by regulatory
mechanisms in which parathyroid hormone-related protein
(PTHrP) and Indian hedgehog (Ihh) play prominent roles
[49]. Other important systemic factors include TGF-, IGF-
1, thyroid hormones and basic FGF [13,50,51]. It is
possible and even likely that the changes in collagen
C.H.A. van de Lest et al. / Biochimica et Biophysica Acta 1690 (2004) 54–62 61metabolism are secondary to events in the upstream regu-
latory mechanisms.
Proteoglycan depletion was present in end-stage lesions,
but not in earlier lesions. This finding is in line with the
results of Lillich et al. [52], who found significantly lower
quantities of uronic acid, GAGs and chondroitin sulfate in
samples from OC cartilage compared to normal cartilage in
a group of 16–24-month-old horses, which, given their age,
must have featured end-stage lesions. Laverty et al. [19]
found no evidence for an increase in proteoglycan degrada-
tion from horses aged 7–12 months. These results indicate
that disturbances of proteoglycan turnover most likely are
no specific sign of early OC, but are a feature of general
joint pathology (as in OA), giving further support for the
discrimination between a pathogenetic phase and a repair
phase within the syndrome of OC.
It is concluded that this study, together with other recent
publications, gives strong support for an important mecha-
nistic role of changes in collagen metabolism during the
early phases of osteochondrosis. The insufficient maturation
and remodelling of the juvenile cartilage will lead to a
thickening of the cartilage layer, but also to a delay in the
normal age-related increase in collagen content and cross-
linking, making the tissue more vulnerable for external
influences. In older lesions, a more general repair process
seems to take place that results in a less specific biochemical
profile of the tissues. However, it should be realised that,
although it seems that changes in collagen metabolism are
of great importance in the pathogenesis of OC (and hence
may be used for diagnostic purposes or even targeted for
therapeutic intervention), it is not likely that these changes
are primary causes of osteochondrosis.Acknowledgements
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